Wei Li Lin
Director/Board Member at HANDA PHARMACEUTICALS, INC.
Wei Li Lin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HANDA PHARMACEUTICALS, INC. | Director/Board Member | 2017-09-27 | - |
| Independent Dir/Board Member | 2017-09-27 | - | |
| Microbio (Shanghai) Co., Ltd. | Director/Board Member | - | - |
| Chuan Fa Biotechnology Co. Ltd. | Chairman | - | - |
Career history of Wei Li Lin
Former positions of Wei Li Lin
| Companies | Position | Start | End |
|---|---|---|---|
| OBI PHARMA, INC. | Director/Board Member | - | 2012-12-19 |
| FOUNTAIN BIOPHARMA INC | Chairman | 2011-11-23 | - |
| Investor Relations Contact | 2011-11-23 | - | |
| President | 2011-11-23 | - |
Training of Wei Li Lin
| Kansas State University | Doctorate Degree |
Statistics
International
| Taiwan | 5 |
| United States | 2 |
| China | 2 |
Operational
| Director/Board Member | 3 |
| Chairman | 2 |
| Investor Relations Contact | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| OBI PHARMA, INC. | Health Technology |
| HANDA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Microbio (Shanghai) Co., Ltd. | |
Fountain Biopharma, Inc.
 Fountain Biopharma, Inc. Pharmaceuticals: OtherHealth Technology Fountain Biopharma, Inc. engages in the research, development and sales of antibody drugs. Its products include anti-allergic monoclonal antibody drugs, monoclonal antibody drugs, immune checkpoint aptamer drugs, anti-lag-3 immunological checkpoint aptamer drugs and anti-tumor stem cell labeled antibody drugs. The company was founded on November 25, 2010 and is headquartered in Taipei, Taiwan. | Health Technology |
| Chuan Fa Biotechnology Co. Ltd. |
- Stock Market
- Insiders
- Wei Li Lin
- Experience
